| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | EVP, Pharm, R&D | SVP, Research &Development
3 companies
Mammen Mathai is a SVP, Research &Development at TBPH with holdings across 3 companies. Recent SEC Form 4 filings include 0 buys and 1 sell.
Estimated insider holdings value: $21.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 11, 2023 | TXG 10x Genomics, Inc. | Director | Sale+OE | 33,000 | $52.82 | $1,743,086.40 | -16.3% | -0.5% | -50.6% |